Displaying 1 - 2 of 2
Article: Benefits and harms of prescription drugs and supplements for treatment of clinical Alzheimer-type dementia: a systematic review and meta-analysis
Image
Description
The article was co-authored by Northwestern Health Sciences University researcher Mary L. Forte. The article was published in Annals of Internal Medicine and was published in 2020.
Abstract
Purpose: To summarize evidence on the effects of prescription drugs and supplements for CATD treatment.
Conclusion: Cholinesterase inhibitors and memantine slightly reduced short-term cognitive decline, and cholinesterase inhibitors slightly reduced reported functional decline, but differences versus placebo were of uncertain clinical importance. Evidence was mostly insufficient on drug treatment of BPSD and on supplements for all outcomes.
Article: Long-term drug therapy and drug holidays for osteoporosis fracture prevention: A systematic review
Image
Description
Report co-written by Northwestern Health Sciences University researcher Mary Forte. The report was prepared by the Minnesota Evidence-based Practice Center for the Agency of Healthcare Research and Quality, U.S. Department of Health and Human Services in April 2019.
Abstract
Objective. To summarize the effects of long-term osteoporosis drug treatment (ODT) and ODT discontinuation and holidays on fractures and harms.